4//SEC Filing
Poole Robert Michael 4
Accession 0001209191-22-007329
CIK 0001636651other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:51 PM ET
Size
5.3 KB
Accession
0001209191-22-007329
Insider Transaction Report
Form 4
Poole Robert Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-03+15,000→ 15,000 totalExercise: $2.72Exp: 2032-02-03→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001871782
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 8:51 PM ET
- Size
- 5.3 KB